These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 6393022)

  • 21. Penicillin treatment for group B streptococcal meningitis in the rhesus monkey.
    Larsen JW; London WT; Palmer AE; Curfman BL; Bronsteen RA
    Obstet Gynecol; 1981 Mar; 57(3):330-4. PubMed ID: 7007941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival and neutrophil kinetics in infants with severe group B streptococcal disease treated with gamma globulin.
    Friedman CA; Robbins KK; Temple DM; Miller CJ; Rawson JE
    J Perinatol; 1996; 16(6):439-42. PubMed ID: 8979181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of interferon-gamma and transforming growth factor-beta on adherence and survival of group B Streptococcus type III strains in ECV304 cells.
    Santos GS; Miyazaki NH; Mattos-Guaraldi AL; Nagao PE
    Int J Mol Med; 2003 Mar; 11(3):401-6. PubMed ID: 12579348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endogenous interleukin-11 (IL-11) expression is increased and prophylactic use of exogenous IL-11 enhances platelet recovery and improves survival during thrombocytopenia associated with experimental group B streptococcal sepsis in neonatal rats.
    Chang M; Williams A; Ishizawa L; Knoppel A; van de Ven C; Cairo MS
    Blood Cells Mol Dis; 1996; 22(1):57-67. PubMed ID: 8807086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Murine type-specific monoclonal antibodies in experimental group B streptococcal infection: interaction with complement components and phagocytes.
    Shigeoka AO
    Semin Perinatol; 1990 Aug; 14(4 Suppl 1):30-9. PubMed ID: 2237468
    [No Abstract]   [Full Text] [Related]  

  • 26. Granulocytic stem cell (CFUc) proliferation in experimental group B streptococcal sepsis.
    Christensen RD; Hill HR; Rothstein G
    Pediatr Res; 1983 Apr; 17(4):278-80. PubMed ID: 6856389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experimental group B streptococcal infection in the rhesus monkey. I. Disease production in the neonate.
    Larsen JW; London WT; Palmer AE; Tossell JW; Bronsteen RA; Daniels M; Curfman BL; Sever JL
    Am J Obstet Gynecol; 1978 Nov; 132(6):686-90. PubMed ID: 102197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic group B streptococcal disease in the neonate: characterization of an oral colonization model using the suckling rat.
    Weisman LE; McKinney L; Villalobos R
    Microbiol Immunol; 1990; 34(9):755-64. PubMed ID: 2149405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood and marrow neutrophils during experimental group B streptococcal infection: quantification of the stem cell, proliferative, storage and circulating pools.
    Christensen RD; MacFarlane JL; Taylor NL; Hill HR; Rothstein G
    Pediatr Res; 1982 Jul; 16(7):549-53. PubMed ID: 7050869
    [No Abstract]   [Full Text] [Related]  

  • 30. Failure of gamma-interferon to decrease mortality from group B streptococcal sepsis in neonatal rats.
    Wittler RR; Harris RW; Paine DD
    Biol Neonate; 1999 Aug; 76(2):125-8. PubMed ID: 10393998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The potential use of monoclonal antibodies as therapeutic modalities in neonatal infection.
    Hill HR; Gonzales LA; Kelsey DK; Raff HV
    Clin Rev Allergy; 1992; 10(1-2):29-38. PubMed ID: 1606522
    [No Abstract]   [Full Text] [Related]  

  • 32. Lung antibacterial defense mechanisms in infant and adult rats: implications for the pathogenesis of group B streptococcal infections in the neonatal lung.
    Martin TR; Rubens CE; Wilson CB
    J Infect Dis; 1988 Jan; 157(1):91-100. PubMed ID: 3275727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neutrophil mobilization induced by complement fragments during experimental group B streptococcal (GBS) infection.
    Shigeoka AO; Gobel RJ; Janatova J; Hill HR
    Am J Pathol; 1988 Dec; 133(3):623-9. PubMed ID: 3059808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose-related protective efficacy of immunoglobulins in experimentally induced group B streptococcal infection.
    Iguchi K; Inoue S
    Acta Paediatr Jpn; 1994 Feb; 36(1):25-9. PubMed ID: 8165904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetics of phagocyte response to group B streptococcal infections in newborn rats.
    Schuit KE; DeBiasio R
    Infect Immun; 1980 May; 28(2):319-24. PubMed ID: 6995304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age-dependent susceptibility of neonatal rats to group B streptococcal type III infection: correlation of severity of infection and response of myeloid pools.
    Zeligs BJ; Armstrong CD; Walser JB; Bellanti JA
    Infect Immun; 1982 Jul; 37(1):255-63. PubMed ID: 7107007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monoclonal antibodies for the diagnosis of infectious diseases.
    Harris MC
    Indian J Pediatr; 1987; 54(4):481-8. PubMed ID: 3308694
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment of experimental group B streptococcal infection with hybridoma antibody.
    Christensen RD; Rothstein G; Hill HR; Pincus SH
    Pediatr Res; 1984 Nov; 18(11):1093-6. PubMed ID: 6393022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating and storage neutrophil changes in experimental type II group B streptococcal sepsis.
    Christensen RD; Shigeoka AO; Hill HR; Rothstein G
    Pediatr Res; 1980 Jun; 14(6):806-8. PubMed ID: 6995919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of hybridoma antibody administration upon neutrophil kinetics during experimental type III group B streptococcal sepsis.
    Christensen RD; Rothstein G; Hill HR; Pincus SH
    Pediatr Res; 1983 Oct; 17(10):795-9. PubMed ID: 6356000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.